Clinical trial · Interventional
Additional Imaging Methods for Assessing Axillary Lymph Node Involvement in Breast Cancer
Additional Radiological Methods for Assessing Axillary Lymph Node Involvement in Breast Cancer
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Breast cancer frequently spreads to the axillary lymph nodes, and accurate assessment of axillary lymph node involvement is essential for staging and treatment planning. Standard imaging methods may not always reliably determine the extent of axillary disease before treatment. This study evaluates the usefulness of additional radiological imaging methods for assessing axillary lymph node involvement in patients with breast cancer. The aim is to improve pre-treatment identification of lymph node metastases and to better estimate the extent of axillary disease.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Axillary Lymph Node Metastasis | Breast Neoplasm | PROBABILISTIC | 0.70 |
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Supplementary Axillary Imaging (Ultrasound Elastography and Contrast-Enhanced Ultrasound) | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Breast Cancer Patients Undergoing Additional Axillary Imaging
- interventionNames
- Diagnostic Test: Supplementary Axillary Imaging (Ultrasound Elastography and Contrast-Enhanced Ultrasound)
Primary outcomes (1)
- measure
- Accuracy of Supplementary Imaging for Detecting Axillary Lymph Node Involvement
- timeFrame
- From baseline imaging assessment until surgery (up to 6 months)
- description
- Diagnostic accuracy of supplementary ultrasound-based imaging methods (elastography and contrast-enhanced ultrasound) for identifying axillary lymph node involvement in breast cancer patients, compared with standard clinical and pathological assessment.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Female patients aged 18 years or older * Diagnosed with breast cancer * Undergoing diagnostic evaluation and treatment at the Institute of Oncology Ljubljana * Ability to provide written informed consent Exclusion Criteria: * Contraindications to contrast-enhanced ultrasound (if applicable) * Inability to undergo required imaging procedures * Withdrawal of informed consent
References
Publications (0)
Data not yet available